Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTP.L Regulatory News (STP)

  • There is currently no data for STP

Director/PDMR Shareholding

15 Jun 2021 12:00

RNS Number : 9632B
Stenprop Limited
15 June 2021
 

 

 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP JSE share code: STP

ISIN: GG00BFWMR296

("Stenprop" or the "Company")

 

 

DEALINGS IN SECURITIES BY DIRECTORS, THE COMPANY SECRETARY AND A PERSON DISCHARGING MANAGERIAL RESPONSIBILITY

 

15 June 2021

 

Shareholders are advised of the following information relating to the acceptance of nil cost options and market value options awarded on 11 June 2021 under the Stenprop Limited Long-Term Incentive Plan (the "LTIP"). The nil cost options will vest on 11 June 2024 subject to certain vesting conditions having been met, including performance targets set by the remuneration committee prior to the awards being made. Assuming that the performance targets are met in full at the end of the performance period, the nil cost options will result in the issue of 834,390 shares. The market value options will vest in three tranches on 31 March 2022, 31 March 2023 and 31 March 2024 and once fully vested will result in the issue of 88,313 shares subject to the payment of the exercise price of £1.5615 per share.

 

Name of director:

Paul Arenson

Transaction date:

11 June 2021

Class of securities:

Nil cost options

Number of securities:

366,058

Nature of transaction

Off-market acceptance of nil cost options in terms of the LTIP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of director:

Julian Carey

Transaction date:

11 June 2021

Class of securities:

Nil cost options

Number of securities:

351,713

Nature of transaction:

Off-market acceptance of nil cost options in terms of the LTIP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of director:

James Beaumont

Transaction date:

11 June 2021

Class of securities:

Nil cost options

Number of securities:

116,619

Nature of transaction:

Off-market acceptance of nil cost options in terms of the LTIP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of company secretary:

Sarah Bellilchi

Transaction date:

11 June 2021

Class of securities:

Market value options

Number of securities:

88,313

Total price payable on exercise:

£137,900.75

Nature of transaction:

Off-market acceptance of market value options in terms of the LTIP

Nature and extent of company secretary's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Shareholders are further advised of the following information relating to the acceptance of nil cost options awarded on 11 June 2021 under the Stenprop Limited Deferred Bonus Plan (the "DBP"). One third of these nil cost options vested immediately, with the second third vesting on 31 March 2022 and the last third vesting on 31 March 2023. Once fully vested, they will result in the issue of 357,884 shares.

 

 

 

Name of director:

Paul Arenson

Transaction date:

11 June 2021

Class of securities:

Nil cost options

Number of securities:

162,248

Nature of transaction:

Off-market acceptance of nil cost options in terms of the DBP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of director:

Julian Carey

Transaction date:

11 June 2021

Class of securities:

Nil cost options

Number of securities:

155,908

Nature of transaction:

Off-market acceptance of nil cost options in terms of the DBP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of director:

James Beaumont

Transaction date:

11 June 2021

Class of securities:

Nil cost options

Number of securities:

25,850

Nature of transaction:

Off-market acceptance of nil cost options in terms of the DBP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of company secretary:

Sarah Bellilchi

Transaction date:

11 June 2021

Class of securities:

Nil cost options

Number of securities:

13,878

Nature of transaction:

Off-market acceptance of nil cost options in terms of the DBP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Finally, shareholders are advised of the following information relating to the exercise of vested market value options and the subsequent disposal of ordinary shares of the Company.

 

Name:

Neil Marais

Position:

Director of Stenprop (Swiss) Limited and Stenprop Trafalgar Limited, being subsidiaries of Stenprop

Transaction date:

11 June 2021

Class of securities:

Market value option

Number of securities exercised:

112,743

Price per security

GBP 0.9348

Total value of the transaction:

GBP 105,397.60

Nature of transaction:

Off-market exercise of market value options

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name:

Neil Marais

Position:

Director of Stenprop (Swiss) Limited and Stenprop Trafalgar Limited, being subsidiaries of Stenprop

Transaction date:

11 June 2021

Class of securities:

Ordinary shares

Number of securities sold:

112,743

Price per security

GBP 1.595

Total value of the transaction:

GBP 179,825.09

Nature of transaction:

On-market sale

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

The Company utilised treasury shares to settle the exercise of the market value options to the above participant. Following this transaction, the total number of treasury shares held by the Company is 12,745,207 and the total number of shares in issue less shares held in treasury is 286,020,968.

 

 

For further information:

 

Stenprop Limited +44(0)20 3918 6600

Paul Arenson (paul.arenson@stenprop.com)

Julian Carey (julian.carey@stenprop.com)

James Beaumont (james.beaumont@stenprop.com)

 

Numis Securities Limited (Financial Adviser) +44(0)20 7260 1000

Hugh Jonathan

Vicki Paine

Justin Bell

 

FTI Consulting +44(0)20 3727 1000

Richard Sunderland stenprop@fticonsulting.com

Richard Gotla

Indraneel Bose

 

Java Capital Trustees and Sponsors Proprietary Limited +27 (0)11 722 3050

(JSE Sponsor)

 

About Stenprop:

 

Stenprop is a UK REIT listed on the LSE and the JSE. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to stenprop.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKPBQKBKDDAD
Date   Source Headline
18th Oct 20077:01 amRNSFinal Results
20th Aug 20077:01 amRNSAIM Rule 26 and Adviser Name
30th Jul 20077:01 amRNSBank Loan Facility
18th Jul 20075:29 pmRNSHolding(s) in Company
28th Jun 20077:03 amRNSTrading Update
18th Jun 20077:01 amRNSMajor VoIP Customer Trial
4th Jun 20074:21 pmRNSNotice of EGM
31st May 20077:00 amRNSTotal Voting Rights
23rd May 200711:43 amRNSDirectorate Change
9th May 20075:04 pmRNSGrant of Options
4th May 20075:40 pmRNSNotifiable Interest
25th Apr 20075:52 pmRNSNotifiable Interest
11th Apr 20075:00 pmRNSHolding(s) in Company
4th Apr 20072:40 pmRNSConvertible Equity Facility
3rd Apr 20078:48 amRNSDirectorate Change
5th Mar 20077:04 amRNSDirectorate Change
5th Mar 20077:01 amRNSAcquisition
5th Feb 20077:02 amRNSTelstra Platinum Partner
2nd Feb 200712:00 pmRNSGrant of Options
30th Jan 20077:02 amRNSInterim Results
11th Dec 20064:15 pmRNSVoting Share capital
6th Dec 20067:01 amRNSDeputy Chairman Appointment
28th Nov 20062:34 pmRNSNotice of EGM
27th Nov 200612:02 pmRNSIssue of Equity
27th Nov 20067:02 amRNSOxfam 118 918 Partnership
30th Oct 20067:02 amRNSAnnual Report and AGM Notice
19th Oct 20067:00 amRNSIssue of Equity
16th Oct 20067:01 amRNSAcquisition
29th Sep 20067:06 amRNSIssue of Equity
12th Sep 20067:04 amRNSAcquisition of Callplan Ltd
29th Aug 20062:15 pmRNSIssue of Equity
28th Jul 20062:06 pmRNSAward of Share Options
27th Jul 200612:29 pmRNSBuy-out of Spiritel Tech
25th Jul 20067:01 amRNSDirector's Dealing
24th Jul 20067:01 amRNSDirector's dealings
21st Jul 200612:27 pmRNSIssue of Equity
19th Jul 200612:13 pmRNSDebt Restructuring
5th Jul 20067:01 amRNSIssue of Convertible Loan
21st Jun 20067:02 amRNSLaunches VoipVoucher
28th Apr 20061:11 pmRNSResult of EGM
6th Apr 20062:08 pmRNSNotice of EGM
6th Apr 20067:01 amRNSBoard Changes
31st Mar 20065:28 pmRNSNotification of Interest
27th Mar 20067:02 amRNSSigns 1st My Phone Agreement
24th Mar 20064:40 pmRNSNotification of Interest
20th Mar 20067:02 amRNSManaged Services Contract
6th Mar 20067:03 amRNSLoan Note Conversion
3rd Mar 20066:27 pmRNSLoan Note Conversion
22nd Feb 20061:39 pmRNSNotification of Interest
21st Feb 20065:50 pmRNSDirectors' Dealing-Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.